Period 1 (NDDG criteria) | Period 2 (C–C criteria) | Interaction test P-value* | |||||
---|---|---|---|---|---|---|---|
Non-GDM (n = 1,213) | GDM (n = 50) | P-value | Non-GDM (n = 2,053) | GDM (n = 210) | P-value | ||
Sex (male) | 605 (49.9) | 30 (60.0) | 0.198 | 1,054 (51.3) | 108 (51.4) | 0.981 | 0.253 |
Birth weight (Kg) | 2.2 ± 0.5 | 2.1 ± 0.6 | 0.120 | 2.2 ± 0.6 | 2.3 ± 0.5 | 0.570 | 0.100 |
SGA | 95 (7.8) | 3 (6.0) | 0.626 | 195 (9.5) | 14 (6.7) | 0.224 | 0.882 |
LGA | 130 (10.7) | 8 (16.0) | 0.201 | 220 (10.7) | 17 (8.1) | 0.251 | 0.087 |
1-min Apgar score < 4 | 48 (4.0) | 5 (10.2) | 0.080 | 31 (1.5) | 7 (3.4) | 0.084 | 0.797 |
5-min Apgar score < 7 | 51 (4.2) | 3 (6.1) | 0.633 | 38 (1.9) | 5 (2.4) | 0.589 | 0.888 |
NICU admission | 518 (43.1) | 24 (49.0) | 0.605 | 735 (36.0) | 80 (38.5) | 0.627 | 0.807 |
Mechanical ventilator | 174 (14.5) | 11 (22.5) | 0.262 | 369 (18.1) | 29 (13.9) | 0.228 | 0.114 |
RDS | 121 (10.1) | 10 (20.4) | 0.077 | 275 (13.5) | 20 (9.6) | 0.229 | 0.033 |
BPD | 29 (2.4) | 0 (0%) | NA | 100 (4.9) | 7 (3.4) | 0.414 | NA |
Sepsis | 83 (6.9) | 5 (10.2) | 0.370 | 129 (6.3) | 11 (5.3) | 0.576 | 0.299 |
TTN | 43 (3.6) | 2 (4.1) | 0.856 | 26 (1.3) | 2 (1.0) | 0.699 | 0.686 |
Hypoglycemia | 72 (6.0) | 2 (4.1) | 0.565 | 36 (1.8) | 10 (4.8) | 0.020 | 0.088 |
Hyperbilirubinemia | 330 (27.5) | 19 (38.8) | 0.194 | 543 (26.6) | 37 (17.8) | 0.027 | 0.023 |
Neonatal death | 16 (1.3) | 0 (0) | NA | 26 (1.3) | 3 (1.4) | 0.840 | NA |
Composite neonatal complicationsa | 638 (53.1) | 29 (59.2) | 0.533 | 1,059 (51.2) | 105 (50.5) | 0.726 | 0.473 |